Mr. Hao is a senior associate and registered U.S. patent attorney at Fox Rothschild LLP, a prominent national general practice law firm.  With more than a decade of legal experience, he serves as counsel to many clients including Fortune 100 companies, startups, entrepreneurs, investors, and academic institutions in biotechnology and pharmaceutical industries on a broad range of business and legal issues, including patent, trademark, licensing, litigation, VC financing, and M&A.  He has prosecuted thousands of patent applications nationally and internationally, including portfolios that resulted in multi-million dollar venture financing and acquisition.  Mr. Hao has provided legal representation to several notable business transactions, including Alexion Pharmaceuticals Inc.’s acquisition of Synageva BioPharma Corp (valued at $8.4 billion), Humanwell Pharmaceutical Group Corporation’s acquisition of Epic Pharma (valued at $550 million), BMS’s acquisition of Amira Pharmaceuticals (valued at $475 million), licensing and collaboration deals involving major universities and companies including the Rockefeller University, Merck, Alnylam, and others. Mr. Hao received a JD from Boston College Law School, a PhD from Columbia University, an MBA from Cornell University, and a BS from Nankai University.